CVRX News

In the US IPO market’s busiest week since 2004, 19 IPOs raised nearly $10 billion, led by Chinese ride-hailing giant DiDi Global (DIDI). The second largest IPO of the year, DiDi (DIDI) upsized and priced at the high end to raise $4.4 billion at a $70.4 billion market cap. DiDi is China’s dominant ride-hailing app, with 15...read more

CVRx, which makes a minimally invasive neuromodulation device for cardiovascular disease, raised $126 million by offering 7 million shares at $18, above the range of $15 to $17. The company offered 0.75 million more shares than anticipated. CVRx manufactures and markets its minimally invasive neuromodulation solutions on its proprietary BAROSTIM platform, which targets imbalances...read more

17 IPOs are slated to raise $9.1 billion in the week ahead, led by long-awaited Chinese ride-hailing giant DiDi Global (DIDI). DiDi (DIDI) plans to raise $3.9 billion at a $67.5 billion market cap. DiDi is China’s dominant ride-hailing app, with 15 million drivers across 4,000 cities and towns. The unprofitable company saw revenue...read more

CVRx, which makes a minimally invasive neuromodulation device for cardiovascular disease, announced terms for its IPO on Wednesday. The Minneapolis, MN-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the midpoint of the proposed range, CVRx would command a fully diluted market value of $333 million. CVRx...read more